Zucara Therapeutics' Corporate Minority Round

Zucara Therapeutics raised a round of funding on September 22, 2017. Investors include JDRF.

Zucara Therapeutics, a spin-off of The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI), is developing drug therapy to prevent hypoglycemia in people with diabetes. The company…

Articles about Zucara Therapeutics' Corporate Minority Round: